Molecular Mining Enters Drug Target Discovery Collaboration with Cytochroma | GenomeWeb

NEW YORK, May 1 - Molecular Mining is using its data mining software in a collaboration with Cytochroma, a Canadian company that uses genomic information to identify and develop drugs that target cytochrome p450 enzymes, the companies said Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.